Peptide therapy should never be done DIY, warns Dr
BPC-157 has been a subject of FDA attention in compounded pharmaceutical contexts, and dietary supplement classifications can change
2025 systematic review in HSS Journal screened the full BPC-157 musculoskeletal literature through June 2024 and found a large preclinical base tendon, ligament, muscle, bone, and nerve injury models but only one published human exposure dataset, the small open-label knee-pain case series
The ordering was so convenient and completely online (I did it on my phone internet)
Therapeutic Goods Administration
Experimental work examining angiogenic responses during muscle and tendon healing reported increased expression of angiogenesis-associated markers such as vascular endothelial growth factor (VEGF), CD34, and factor VIII within injured tissues following BPC-157 exposure [6]